Literature DB >> 18008020

Specific effects of gamma-linolenic, eicosapentaenoic, and docosahexaenoic ethyl esters on bone post-ovariectomy in rats.

R C Poulsen1, E C Firth, C W Rogers, P J Moughan, M C Kruger.   

Abstract

Long chain polyunsaturated fatty acids (LCPUFAs) are involved in the regulation of bone metabolism. Increased dietary consumption of n-3, and possibly some n-6, LCPUFAs may limit postmenopausal bone loss. The aim of this study was to determine the effects on bone of specific fatty acids within the n-3 and n-6 LCPUFA families in ovariectomized (OVX) rats. Rats were OVX or sham-operated and fed either a control diet (OVX and sham) or a diet supplemented with 0.5 g/kg body weight/day of gamma-linolenic (GLA), eicosapentaenoic (EPA), docosahexaenoic (DHA) ethyl esters or a mixture of all three (MIX) for 16 weeks. Bone mineral content (BMC), area, and density and plasma concentrations of insulin-like growth factor-I, vitamin D, selected biochemical markers of bone metabolism, and parathyroid hormone (PTH) were determined. The OVX-induced decrease in lumbar spine BMC was significantly attenuated by DHA but not by EPA or GLA supplementation or supplementation with a mixture of all three LCPUFAs. Endosteal circumferences of tibiae were significantly greater in DHA and EPA compared to OVX. Plasma C-terminal telopeptide of type I collagen and osteocalcin concentrations were not significantly different in the DHA group compared to OVX. Femur BMC decreased by a significantly greater amount in GLA than OVX, and final plasma PTH concentrations were significantly higher in GLA compared to all other groups. In conclusion, DHA ameliorated OVX-induced bone mineral loss. GLA exacerbated post-OVX bone mineral loss, possibly as a result of PTH-induced bone catabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18008020     DOI: 10.1007/s00223-007-9080-7

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  3 in total

1.  DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA.

Authors:  Md Mizanur Rahman; Jyothi Maria Veigas; Paul J Williams; Gabriel Fernandes
Journal:  Breast Cancer Res Treat       Date:  2013-09-24       Impact factor: 4.872

2.  Providing Flaxseed Oil but Not Menhaden Oil Protects against OVX Induced Bone Loss in the Mandible of Sprague-Dawley Rats.

Authors:  Amanda B Longo; Wendy E Ward
Journal:  Nutrients       Date:  2016-09-24       Impact factor: 5.717

3.  Bone Benefits of Fish Oil Supplementation Depend on its EPA and DHA Content.

Authors:  Haissam Abou-Saleh; Allal Ouhtit; Ganesh V Halade; Md Mizanur Rahman
Journal:  Nutrients       Date:  2019-11-08       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.